Improvement in Drug-Induced Parkinsonism With Electroconvulsive Therapy

Kennedy, 2003, Electroconvulsive therapy in movement disorders: an update, J Neruopsychiatry Clin Neurosci, 15, 407, 10.1176/appi.neuropsych.15.4.407 Naranjo, 1981, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, 30, 239, 10.1038/clpt.1981.154 Barbosa, 2006, Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambuí study), Mov Disord., 21, 800, 10.1002/mds.20806 Benito-León, 2003, Prevalence of PD and other types of parkinsm in three elderly populations of central Spain, Mov Disord, 18, 267, 10.1002/mds.10362 Caligiuri, 2000, Antypsychotic-induced movement disorders in the elderly: epidemiology and treatment recommendations, Drugs Aging, 17, 363, 10.2165/00002512-200017050-00004 Alvarez, 2008, Understanding drug-induced parkinsonism: separating pearls from oysters, Neurology, 19, e32, 10.1212/01.wnl.0000302255.49113.51 Lera, 1999, Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism, Mov Disord, 14, 128, 10.1002/1531-8257(199901)14:1<128::AID-MDS1021>3.0.CO;2-J Janno, 2004, Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients, Am J Psychiatry, 161, 160, 10.1176/appi.ajp.161.1.160 Pierre, 2005, Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management, Drug Saf, 28, 191, 10.2165/00002018-200528030-00002 Tarsy, 2002, Effects of newer antipsychotics on extrapyramidal function, CNS Drugs, 16, 23, 10.2165/00023210-200216010-00003 Llau, 1994, Drug-induced parkinsonian síndromes: a 10-year experience at a regional center of pharmaco-vigilance, Rev Neurol (Paris), 150, 757 Hardie, 1988, Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa, J Neurol Neurosurg Psychiatry, 51, 850, 10.1136/jnnp.51.6.850 Thanvi, 2009, Drug induced parkinsonism: a common cause of parkinsonism in older people, Postgrad Med J, 85, 322, 10.1136/pgmj.2008.073312 Cortese, 2008, Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia, J Clin Psychopharmacol, 28, 69, 10.1097/jcp.0b013e318160864f Popeo, 2009, ECT for Parkinson's disease, Med Hypotheses, 73, 468, 10.1016/j.mehy.2009.06.053 Jamora, 2007, Valproate-induced Parkinsonism in epilepsy patients, Mov Disord, 22, 130, 10.1002/mds.21188 Zadikoff, 2007, Movement disorders in patients taking anticonvulsants, J Neurol Neurosurg Psychiatry, 78, 147, 10.1136/jnnp.2006.100222 Dallocchio, 2002, A case of Parkinsonism due to lithium intoxication: treatment with Pramipexole, J Clin Neurosci, 9, 310, 10.1054/jocn.2001.1033 Thanvi, 2005, Vascular parkinsonism–an important cause of parkinsonism in older people, Age Ageing, 34, 114, 10.1093/ageing/afi025 Schillevoort, 2002, Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports, Int Clin Psychopharmacol, 17, 75, 10.1097/00004850-200203000-00006 Kim, 2009, Non-motor cognitive-perceptual dysfunction associated with drug-induced parkinsonism, Hum Psychopharmacol, 24, 129, 10.1002/hup.1009